Category: Uncategorized

???? Novartis Acquires Anthos Therapeutics for Up to $3.1 Billion to Boost Cardiovascular Pipeline

06/12/2025 Published by vivi

The Swiss pharmaceutical giant Novartis has reached an agreement to acquire Anthos Therapeutics, a biopharmaceutical firm majority-owned by the life... Read more

Tags: #M&A

Merck Finalizes $3.4 Billion Acquisition, Enhancing Rare Tumor Portfolio

06/12/2025 Published by vivi

Merck has successfully completed its previously announced $3.4 billion acquisition of SpringWorks Therapeutics, a biopharmaceutical company based in Stamford, Connecticut.... Read more

Category: Uncategorized

Tags: #M&A

Roche Commits $3.5 Billion to Bolster MASH Portfolio via 89bio Acquisition

06/12/2025 Published by vivi

Roche has announced its plan to acquire 89bio, a San Francisco-based biotechnology firm, in a strategic move valued at approximately... Read more

Category: Uncategorized

Tags: #M&A

Novo Nordisk Secures Key MASH Therapy in $5.2 Billion Strategic Deal

06/12/2025 Published by vivi

Global pharmaceutical giant Novo Nordisk has significantly strengthened its position in the treatment landscape for Metabolic Dysfunction-associated Steatohepatitis (MASH) with... Read more

Category: Uncategorized

Tags: #M&A

Merck Finalizes $10 Billion Acquisition of Verona Pharma with No Competing Bids

06/12/2025 Published by vivi

Merck successfully completed its $10 billion acquisition of Verona Pharma last month, a deal notable for the absence of a... Read more

Category: Uncategorized

Tags: #M&A

Johnson & Johnson Expands Neuroscience Portfolio with $14.6 Billion Acquisition

06/12/2025 Published by vivi

Global healthcare leader Johnson & Johnson (J&J) commenced the J.P. Morgan Healthcare Conference by announcing its intent to acquire Intra-Cellular... Read more

Category: Uncategorized

Tags: #M&A

Pharmaceutical Giant Finalizes Acquisition of Obesity Drug Developer

06/12/2025 Published by vivi

The global pharmaceutical corporation Pfizer Inc. has announced the successful conclusion of its acquisition of the clinical-stage biotechnology firm, Metsera,... Read more

Category: Uncategorized

Tags: #M&A

Vetter Managing Director to Retire Following Over Three Decades of Service

05/12/2025 Published by vivi

Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has announced the retirement of its Managing Director, Thomas Otto,... Read more

Category: Uncategorized

Tags: #Global Trends